/
Other
Pilot Study
26
Pipeline Programs↗
20
Active Trials↗
39
Companies Involved↗
Pilot Study is an emerging landscape with 26 programs across 39 companies. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Preclinical19
Phase 13
Approved
No programs
Analysis
Modality Breakdown
96%
Small molecule
23 of 24 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 24 classified programs, each share of the total. Modality classified for 100% of 26 pipeline programs.
Analysis
Trial Status
325
clinical trials
Completed221 · 68%
Terminated35 · 11%
Unknown status29 · 9%
Withdrawn20 · 6%
Recruiting10 · 3%
Active, not recruiting5 · 2%
Other5 · 2%
Clinical Trials
Trial Activity
325 trials
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Recruiting·—·Phase 1·NCT06062745·30 enrolled
Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study
Recruiting·—·Phase 4·NCT07133659·25 enrolled
Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study
Active, not recruiting·TTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation·Phase 4·NCT05782972·50 enrolled
Page 1 of 22
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)